PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 61 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,067 | +80.1% | 137,809 | 0.0% | 0.00% | – |
| Q2 2023 | $22,807 | -81.2% | 137,809 | +11.0% | 0.00% | – |
| Q1 2023 | $121,130 | +8.1% | 124,109 | +15.2% | 0.00% | – |
| Q4 2022 | $112,026 | -9.7% | 107,717 | 0.0% | 0.00% | – |
| Q3 2022 | $124,000 | -38.3% | 107,717 | 0.0% | 0.00% | – |
| Q2 2022 | $201,000 | -40.7% | 107,717 | -3.7% | 0.00% | – |
| Q1 2022 | $339,000 | -19.7% | 111,853 | +0.1% | 0.00% | – |
| Q4 2021 | $422,000 | -28.4% | 111,689 | -1.9% | 0.00% | – |
| Q3 2021 | $589,000 | +27.2% | 113,878 | -5.8% | 0.00% | – |
| Q2 2021 | $463,000 | -67.9% | 120,846 | -78.4% | 0.00% | – |
| Q1 2021 | $1,441,000 | -0.7% | 560,674 | -3.4% | 0.00% | – |
| Q4 2020 | $1,451,000 | +24.7% | 580,546 | +3.2% | 0.00% | – |
| Q3 2020 | $1,164,000 | -35.4% | 562,696 | -3.1% | 0.00% | – |
| Q2 2020 | $1,801,000 | +44.7% | 580,853 | +6.3% | 0.00% | – |
| Q1 2020 | $1,245,000 | -35.4% | 546,240 | +2.6% | 0.00% | – |
| Q4 2019 | $1,927,000 | +5.8% | 532,159 | -0.4% | 0.00% | – |
| Q3 2019 | $1,821,000 | -18.0% | 534,213 | +13.0% | 0.00% | -100.0% |
| Q2 2019 | $2,221,000 | +37.3% | 472,617 | -2.1% | 0.00% | – |
| Q1 2019 | $1,618,000 | +31.8% | 482,943 | +4.6% | 0.00% | – |
| Q4 2018 | $1,228,000 | -55.0% | 461,925 | -5.1% | 0.00% | -100.0% |
| Q3 2018 | $2,726,000 | +52.4% | 486,690 | +37.9% | 0.00% | – |
| Q2 2018 | $1,789,000 | -26.1% | 352,939 | -0.6% | 0.00% | -100.0% |
| Q1 2018 | $2,422,000 | +0.8% | 355,208 | +11.6% | 0.00% | 0.0% |
| Q4 2017 | $2,403,000 | +30.0% | 318,294 | -0.9% | 0.00% | – |
| Q3 2017 | $1,849,000 | +13.8% | 321,134 | +0.0% | 0.00% | – |
| Q2 2017 | $1,625,000 | +3432.6% | 321,118 | +1184.5% | 0.00% | – |
| Q3 2016 | $46,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,136,319 | $3,443,000 | 3.20% |
| Aquilo Capital Management, LLC | 3,708,882 | $11,238,000 | 1.65% |
| Soleus Capital Management, L.P. | 4,134,868 | $12,529,000 | 1.62% |
| GREAT POINT PARTNERS LLC | 2,199,076 | $6,663,000 | 1.61% |
| BVF INC/IL | 5,328,239 | $16,145,000 | 0.65% |
| Cutter & CO Brokerage, Inc. | 406,229 | $1,231,000 | 0.37% |
| WEALTH EFFECTS LLC | 80,400 | $244,000 | 0.11% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,028,322 | $3,116,000 | 0.10% |
| Rhenman & Partners Asset Management AB | 300,000 | $909,000 | 0.09% |
| Woodline Partners LP | 1,587,475 | $4,810,000 | 0.08% |